BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Viswanath A, Fouda S, Fernandez CJ, Pappachan JM. Metabolic-associated fatty liver disease and sarcopenia: A double whammy. World J Hepatol 2024; 16(2): 152-163 [PMID: 38495287 DOI: 10.4254/wjh.v16.i2.152]
URL: https://www.wjgnet.com/1948-5182/full/v16/i2/152.htm
Number Citing Articles
1
Aili Fan, Jie Zhang, Qing Ye. Osteosarcopenia in metabolic dysfunction–associated steatotic liver disease: from mechanisms to managementFrontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1706068
2
Marina Ribas Losasso, Maria Luiza Cesto Parussolo, Antony Oliveira Silva, Rosa Direito, Karina Quesada, Claudia Rucco Penteado Detregiachi, Marcelo Dib Bechara, Nahum Méndez-Sánchez, Ludovico Abenavoli, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Elen Landgraf Guiger, Lucas Fornari Laurindo, Sandra Maria Barbalho. Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and SarcopeniaInternational Journal of Molecular Sciences 2025; 26(10): 4673 doi: 10.3390/ijms26104673
3
G.V. Shavkuta, V.A. Gavrilyukov, V.N. Kovalenko, A.S. Zubkova, Z.M. Nalgieva. Non-alcoholic fatty liver disease, metabolic dysfunction and sarcopeniaTerapevt (General Physician) 2025; (6): 60 doi: 10.33920/MED-12-2506-06
4
Longshan Yang, Xiaojun Zeng. Lean-MAFLD: imperatives for updated evidence, mechanistic clarity, and methodological rigorHepatology International 2025; 19(4): 974 doi: 10.1007/s12072-025-10832-4
5
Yilin Wen, Ping Weng, Yueyue Li, Liming Yang, Chengju Li, Qingyang Chen, Yanni He, Wanping Zhang, Hui Hu, Zhiyi Yuan, Chao Yu. Triglyceride-Targeted Molecularly Imprinted Polymers Activate Lipophagy via Cargo Exchange for Nonalcoholic Fatty Liver Disease TreatmentACS Applied Polymer Materials 2024; 6(12): 7265 doi: 10.1021/acsapm.4c01222
6
Carlo Acierno, Fannia Barletta, Alfredo Caturano, Riccardo Nevola, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Luca Rinaldi. Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological InsightsNutrients 2025; 17(13): 2229 doi: 10.3390/nu17132229
7
Anuththara Upamali Abeykoon, Madhavi Priyanka Paranagama, Kavindra Kumara Wijesundera, Onela Canith Pathirana, Thilini Anupama Mahakapuge, Jayantha Rajapakse. In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse modelBMC Complementary Medicine and Therapies 2025; 25(1) doi: 10.1186/s12906-025-04918-7
8
Hery Djagat Purnomo, Randy Adiwinata, Cecilia Oktaria Permatadewi, Hesti Triwahyu Hutami, Didik Indiarso. The global landscape of lean metabolic dysfunction-associated steatotic liver disease: insight from Asia and the WestFrontiers in Gastroenterology 2025; 4 doi: 10.3389/fgstr.2025.1699508
9
P.J. Tárraga Marcos, Á.A. López-González, E. Martínez-Almoyna Rifá, H. Paublini Oliveira, C. Martorell Sánchez, P.J. Tárraga López, J.I. Ramírez-Manent. Riesgo de enfermedad del hígado graso asociada a la disfunción metabólica en 44.939 trabajadores sanitarios españoles: variables asociadasMedicina de Familia. SEMERGEN 2025; 51(7): 102514 doi: 10.1016/j.semerg.2025.102514
10
Bryan Adrian Priego-Parra, Berenice M Román-Calleja, Rocio Gallego-Duran, Jordi Gracia-Sancho, Jose Antonio Velarde Ruiz-Velasco, Jose Maria Remes-Troche. Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver diseaseWorld Journal of Hepatology 2025; 17(7): 107668 doi: 10.4254/wjh.v17.i7.107668
11
Chunyu Wang, Kunjing Liu, Jing Ji, Wenyuan Ma, Haojia Zhang, Kai Wang, Yukun Lin, Chongyang Ma, Xueqian Wang, Fafeng Cheng. Liu-Jun-Zi decoction alleviates metabolic dysfunction-associated steatohepatitis by modulating myogenic irisin mediated skeletal muscle-liver crosstalkPhytomedicine 2025; 148: 157218 doi: 10.1016/j.phymed.2025.157218
12
Gholam Reza Sivandzadeh, Ali Shahsavari, Elahe Meftah, Ramin Niknam, Ali Reza Safarpour. Effect of L-carnitine supplementation on muscle cramps in liver cirrhosis: results from a retrospective cohort studyBMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03730-4
13
Helai Hussaini, Fikadu Woreta, Olga Sarah, Olaniyi Fadeyi, Rahman Hameed Mohammed Abdul, Sonalben Chaudhary, Mohammed Qasim Rauf, Shamsha Hirani. Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: A Systematic Review and Meta-analysisCureus 2025;  doi: 10.7759/cureus.94766
14
Rochelle Wong, Li-Yun Yuan. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address bothWorld Journal of Hepatology 2024; 16(6): 871-877 doi: 10.4254/wjh.v16.i6.871
15
Sandra Maria Barbalho, Lucas Fornari Laurindo, Vitor Engracia Valenti, Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, Ricardo de Alvares Goulart. Organokine-Mediated Crosstalk: A Systems Biology Perspective on the Pathogenesis of MASLD—A Narrative ReviewInternational Journal of Molecular Sciences 2025; 26(23): 11547 doi: 10.3390/ijms262311547